Blom AM

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.

Xu Z, Xu B, Lundström SL, ..., Zubarev RA, Holmdahl R

Nat Commun 14 (1) 5949 [2023-09-23; online 2023-09-23]

Drug Discovery and Development (DDD) [Collaborative]

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

von Palffy S, Thorsson H, Peña-Martínez P, ..., Lilljebjörn H, Fioretos T

Blood Adv 7 (7) 1204-1218 [2023-04-11; online 2022-11-17]

Clinical Genomics Lund [Service]

Nontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance.

Thofte O, Bettoni S, Su Y, ..., Blom AM, Riesbeck K

J. Immunol. 207 (6) 1566-1577 [2021-09-15; online 2021-08-25]

Integrated Microscopy Technologies Umeå [Collaborative]